PMC:5400020 / 1536-1854 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/5400020","sourcedb":"PMC","sourceid":"5400020","source_url":"https://www.ncbi.nlm.nih.gov/pmc/5400020","text":"CONCLUSIONS: The SAVI-registries have confirmed that transapical implantation using the ACURATE TATM device is safe and effective in an all-comers setting with low complication rates and stable performance outcomes at short-term and 1 year; outcomes were similar between SAVI-1 and -2. ClinicalTrials.gov: NCT02663375\n","tracks":[]}